Hepatitis B and hepatitis C virus infections among antiretroviral-naive and -experienced HIV co-infected adults

Journal of Medical Microbiology

Volumn 63, Issue PART 5, 2014, Pages 742-747

  Manyazewal, Tsegahun ^a   Sisay, Zufan ^a   Biadgilign, Sibhatu ^b   Abegaz, Woldaregay Erku ^a  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

^b JIMMA UNIVERSITY   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; HEPATITIS C VIRUS ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADULT; ADULT DISEASE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHIOPIA; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOAFFINITY CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROLOGY; SEROPREVALENCE;

ADULT; COINFECTION; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETHIOPIA; FEMALE; HEALTHY VOLUNTEERS; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HUMANS; IMMUNOCHROMATOGRAPHY; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 84899145894     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.063321-0     Document Type: Article

References (24)

1. Abebe, A., Nokes, D. J., Dejene, A., Enquselassie, F., Messele, T. & Cutts, F. T. (2003). Seroepidemiology of hepatitis B virus in Addis Ababa, Ethiopia: transmission patterns and vaccine control. Epidemiol Infect 131, 757-770.
2. Ayele, W., Nokes, D. J., Abebe, A., Messele, T., Dejene, A., Enquselassie, F., Rinke de Wit, T. F. & Fontanet, A. L. (2002). Higher prevalence of anti-HCV antibodies among HIV-positive compared to HIV-negative inhabitants of Addis Ababa, Ethiopia. J Med Virol 68, 12-17.
3. Barth, R. E., Huijgen, Q., Taljaard, J. & Hoepelman, A. I. (2010). Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and metaanalysis. Int J Infect Dis 14, e1024-e1031.
4. FMOH (2007). Guidelines for HIV Counseling and Testing in Ethiopia. Addis Ababa, Ethiopia: Federal HIV/AIDS Prevention and Control Office, Federal Democratic Republic of Ethiopia Ministry of Health. http://www.ilo.org/wcmsp5/groups/public/---ed_protect/---protrav/--- ilo_aids/documents/legaldocument/wcms_125384.pdf
5. Frommel, D., Tekle-Haimanot, R., Berhe, N., Aussel, L., Verdier, M., Preux, P. M. & Denis, F. (1993). A survey of antibodies to hepatitis C virus in Ethiopia. Am J Trop Med Hyg 49, 435-439.
6. Ghany, M. G., Strader, D. B., Thomas, D. L., Seeff, L. B. & American Association for the Study of Liver Diseases (2009). Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49, 1335-1374.
7. Graham, C. S., Baden, L. R., Yu, E., Mrus, J. M., Carnie, J., Heeren, T. & Koziel, M. J. (2001). Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis 33, 562-569.
8. Hsu, Y. S., Chien, R. N., Yeh, C. T., Sheen, I. S., Chiou, H. Y., Chu, C. M. & Liaw, Y. F. (2002). Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 35, 1522-1527.
9. Koziel, M. J. & Peters, M. G. (2007). Viral hepatitis in HIV infection. N Engl J Med 356, 1445-1454.
10. Lada, O, Benhamou, Y., Poynard, T. & Thibault, V. (2006). Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variants. J Virol 80, 2968-2975.
11. Lee, J. M. & Ahn, S. H. (2011). Quantification of HBsAg: basic virology for clinical practice. World J Gastroenterol 17, 283-289.
12. Manyazewal, T, Paterniti, A. D., Redfield, R. R. & Marinucci, F. (2013). Role of secondary level laboratories in strengthening quality at primary level health facilities' laboratories: an innovative approach to ensure accurate HIV, tuberculosis, and malaria test results in resource-limited settings. Diagn Microbiol Infect Dis 75, 55-59.
13. Miller, L. C. (2005). International adoption: infectious diseases issues. Clin Infect Dis 40, 286-293.
14. Rao, T. V., Suseela, I. J. & Sathiavathy, K. A. (2008). Estimation of antibodies to HBsAg in vaccinated health care workers. Indian J Med Microbiol 26, 93-94.
15. Rusine, J, Ondoa, P., Asiimwe-Kateera, B., Boer, K. R., Uwimana, J. M., Mukabayire, O., Zaaijer, H., Mugabekazi, J., Reiss, P. & van de Wijgert, J. H. (2013). High seroprevalence of HBV and HCV infection in HIV-infected adults in Kigali, Rwanda. PLoS ONE 8, e63303.
16. Saha, D, Pal, A., Biswas, A., Panigrahi, R., Sarkar, N., Sarkar, J., Pal, M., Guha, S. K., Saha, B. &other authors (2013). Characterization of treatment-naive HIV/HBV co-infected patients attending ART clinic of a tertiary healthcare centre in eastern India. PLoS ONE 8, e73613.
17. Shimelis, T, Torben, W., Medhin, G., Tebeje, M., Andualm, A., Demessie, F., Mulu, A., Tegbaru, B. & Gebre-Selassie, S. (2008) Hepatitis B virus infection among people attending the voluntary counselling and testing centre and anti-retroviral therapy clinic of St Paul's General Specialised Hospital, Addis Ababa, Ethiopia. Sex Transm Infect 84, 37-41.
18. Soriano, V, Mocroft, A., Peters, L., Rockstroh, J., Antunes, F., Kirkby, N., de Wit, S., d'Arminio Monforte, A., Flisiak, R. & Lundgren, J. (2010). Predictors of hepatitis B virus genotype and viraemia in HIVinfected patients with chronic hepatitis B in Europe. J Antimicrob Chemother 65, 548-555.
19. Taye, S. & Lakew, M. (2013). Impact of hepatitis C virus co-infection on HIV patients before and after highly active antiretroviral therapy: an immunological and clinical chemistry observation, Addis Ababa, Ethiopia. BMC Immunol 14, 23.
20. Taylor, L. E., Swan, T. & Mayer, K. H. (2012). HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms. Clin Infect Dis 55 (Suppl. 1), S33-S42.
21. Thio, C. L., Seaberg, E. C., Skolasky, R., Jr, Phair, J., Visscher, B., Muñoz, A., Thomas, D. L. & Multicenter AIDS Cohort Study (2002). HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360, 1921-1926.
22. WHO (2011). Prevention& Control of Viral Hepatitis Infection: a Strategy for Global Action. Geneva: World Health Organization. http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=18000&Itemid=
23. WHO (2012). Prevention & Control of Viral Hepatitis Infection: Framework for Global Action. Geneva: World Health Organization. http://www.who.int/csr/disease/hepatitis/GHP_framework.pdf
24. WHO(2013). Global Policy Report on the Prevention and Control of Viral Hepatitis in WHO Member States. Geneva:World Health Organization. http://apps.who.int/iris/bitstream/10665/85397/1/9789241564632_eng. pdf